Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.04
HEPI's Cash to Debt is ranked lower than
58% of the 769 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.62 vs. HEPI: 0.04 )
HEPI' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.04

F-Score: 3
Z-Score: -54.25
M-Score: -12.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
ROA (%) -464.40
HEPI's ROA (%) is ranked lower than
59% of the 744 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 3.87 vs. HEPI: -464.40 )
HEPI' s 10-Year ROA (%) Range
Min: -7281.13   Max: -352.49
Current: -464.4

-7281.13
-352.49
ROC (Joel Greenblatt) (%) -3308.51
HEPI's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 738 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 15.90 vs. HEPI: -3308.51 )
HEPI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -18705.88   Max: -620.51
Current: -3308.51

-18705.88
-620.51
EPS Growth (%) 4.00
HEPI's EPS Growth (%) is ranked higher than
71% of the 593 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.40 vs. HEPI: 4.00 )
HEPI' s 10-Year EPS Growth (%) Range
Min: 0   Max: 448.5
Current: 4

0
448.5
» HEPI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEPI



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT -6.77
HEPI's EV-to-EBIT is ranked higher than
55% of the 805 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 33.37 vs. HEPI: -6.77 )
HEPI' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -6.77

Valuation & Return

vs
industry
vs
history
Forward Rate of Return (Yacktman) -15.70
HEPI's Forward Rate of Return (Yacktman) is ranked higher than
54% of the 615 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 3.56 vs. HEPI: -15.70 )
HEPI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -15.7

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic
Compare:TKPYY, AGN, FRX, MRX, ESALF » details
Health Enhancement Products, Inc., was incorporated under the laws of the State of Nevada on March 28, 1983 under the name of L. Peck Enterprises, Inc. On May 27, 1999 it changed its name to Western Glory Hole, Inc. on October 30, 2003, the Company acquired the outstanding shares of Health Enhancement Corporation and in connection with this transaction it changed its name to Health Enhancement Product, Inc. The Company is a health & wellness company engaged in the research and development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
» More Articles for HEPI

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
New Research Yields Promising Results for Supporting Canine Joint Health, Points to Dietary... Jun 30 2014
HEALTH ENHANCEMENT PRODUCTS INC Financials May 21 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-Q, Quarterly Report May 14 2014
Health Enhancement Products, Inc. Reveals Results From Canine Joint Health Study Conducted by... May 05 2014
Health Enhancement Products Announces Commencement of Bovine Mastitis Testing With Contract Research... Apr 24 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Other Events Apr 21 2014
Health Enhancement Products, Inc.'s President's Annual Report to Shareholders Mar 31 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Other Events Mar 31 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-K, Annual Report Mar 31 2014
Health Enhancement Products Announces Start of Canine Joint Health Testing and Phase Two Synthetic... Mar 17 2014
Health Enhancement Products, Inc. Study at the University of Missouri Indicates Positive Results for... Feb 03 2014
Health Enhancement Products, Inc. Enters Into Collaborative Agreement With Global Animal Health... Dec 26 2013
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Financial Statements and Exhibits Dec 23 2013
Health Enhancement Products, Inc. Expands Corporate Website, Launches Wellness Testing Subsidiary... Dec 03 2013
Health Enhancement Products, Inc. Sponsored Research at University of Wisconsin - Madison Yields... Nov 20 2013
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-Q, Quarterly Report Nov 12 2013
Health Enhancement Products, Inc. Sponsors Research at Arizona Center for Algae Technology and... Nov 12 2013
Health Enhancement Products Subsidiary WellMetris LLC to Launch Multi-City Pilot Study Jointly... Nov 05 2013
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... Aug 27 2013
Health Enhancement Products, Inc. Acquires the Assets and Intellectual Property of Wellness Testing... Aug 26 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide